- Home
- Equipment
- usa new york
- parkinsons disease
Show results for
Refine by
Parkinsons Disease Equipment Supplied In Usa New York
6 equipment items found
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism oflevodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain barrier for central nervous system effect.http://www.creative-peptides.com/product/carbidopa-item-10-101-135-25.html ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Pergolide mesylate salt is a methanesulfonate salt obtained from pergolide by mixing eqimolar amount of pergolide and methanesulfonic acid. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used in the management of Parkinson's disease and ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Neuroscience is a heterogeneous field, requiring integrated analysis of multiple cell types, tissues and organs using diverse techniques. Prevention and effective treatment of neurological disorders like Alzheimer's and Parkinson's diseases has been a major medical challenge. ...
Manufactured by:Acorda Therapeutics, Inc. based inPearl River, NEW YORK (USA)
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa ...
Manufactured by:Population Bio, Inc. a Precision Medicine Company based inMelville, NEW YORK (USA)
Population Bio’s patented CNV Beacon® platform is a rapid genetic discovery method that focuses first on identifying disease-relevant copy number variants (CNVs). Once a gene or genomic region is discovered via a CNV, other types of genetic variants – such as single nucleotide variants (SNVs) – can be efficiently revealed to determine the full spectrum of variants that cause ...
Manufactured by:BlueRock Therapeutics based inCambridge, MASSACHUSETTS (USA)
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. ...